Source: daily_prices:fmp_change_percent
Changes History →Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
Investment research built around change detection.
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
What changed: Moderna, Inc. (MRNA) moved +50.30% from $116.02 to $174.38 on 2026-08-19 on continued investor optimism around Phase 3 clinical milestone data for its personalized mRNA cancer vaccines (developed with Merck) and progress across its non-COVID infectious disease and latent virus programs. Volume surged to 34.0x the 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →Moderna reports earnings on 2026-11-05 (consensus EPS estimate −$1.38).
What changed: Twist Bioscience Corporation (TWST) moved +10.86% from $128.44 to $142.39 on 2026-08-19, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Source: daily_prices:fmp_change_percent
Changes History →TWST earnings on 2026-11-13 (consensus EPS estimate: −$0.44); monitor for any pre-earnings guidance or strategic announcements.
What changed: Hims & Hers Health, Inc. (HIMS) moved +12.85% from $27.55 to $31.09 on 2026-08-19. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.7x the 5-day average, modestly elevated.
Source: daily_prices:fmp_change_percent
Changes History →Monitor for earnings on 2026-11-02 and compare reported EPS to the $0.12 consensus estimate.
What changed: MaxLinear, Inc. (MXL) moved -10.77% from $74.45 to $66.43 on 2026-08-19. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.1x, indicating the decline occurred without unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →MXL earnings report expected 2026-10-22 (consensus EPS estimate $0.56).
What changed: Vicor Corporation (VICR) moved -10.19% from $242.00 to $217.35 on 2026-08-19. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found in available sources. Volume was 1.3x the 5-day average, modestly elevated.
Source: daily_prices:fmp_change_percent
Changes History →VICR earnings scheduled for 2026-10-20; consensus EPS estimate is $0.85.
What changed: Tempus AI, Inc. (TEM) moved +9.53% from $55.85 to $61.17 on 2026-08-19. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move was accompanied by volume 6.8x the 5-day average and pushed the stock to a new 30-day high.
Source: daily_prices:fmp_change_percent
Changes History →Monitor for news or filings that may explain the volume spike, and track whether the stock holds above $61 support ahead of November earnings.
What changed: Reliance Steel & Aluminum Co. (RS) moved -5.56% from $422.84 to $399.31 on 2026-08-19. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The decline appears driven by profit-taking in industrial and materials stocks following RS's strong multi-month rally and approach to 52-week highs, with volume at 2.4x the 5-day average indicating institutional selling.
Source: daily_prices:fmp_change_percent
Changes History →Q3 2026 earnings announcement (2026-10-21) to confirm whether the company maintains earnings momentum or signals weakness in industrial demand.
What changed: Circle Internet Group (CRCL) moved +6.54% from $73.77 to $78.59 on 2026-08-19, driven by a broader crypto market rally fueled by falling Treasury yields, rising Bitcoin prices, and renewed legislative optimism around the CLARITY Act. Volume surged to 2.4x the 5-day average, and the stock reached a new 30-day high.
Source: daily_prices:fmp_change_percent
Changes History →CRCL earnings are scheduled for 2026-11-11, with consensus EPS estimate of $0.29.
What changed: Steel Dynamics, Inc. (STLD) moved -8.53% from $252.56 to $231.01 on 2026-08-19. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific negative catalyst was found. The move occurred on volume 3.0x the 5-day average and appears to reflect profit-taking following a strong multi-month rally, with news sources characterizing recent minor pullbacks as normal consolidation in the materials sector.
Source: daily_prices:fmp_change_percent
Changes History →Monitor STLD's 2026-10-19 earnings release for actual EPS results versus the $5.31 consensus estimate.
What changed: Coinbase Global, Inc. (COIN) moved +8.61% from $147.50 to $160.20 on 2026-08-19, driven by a sharp cryptocurrency market rally in which Bitcoin jumped over 7% to near $69,500 and Ethereum climbed past $2,100. The move was amplified by high-profile policy discussions between crypto industry leaders—including Coinbase representatives—and White House administration officials, along with continued investor enthusiasm around Coinbase's expansion into tokenization, stablecoin payments, and AI-agent payment protocols. Volume was 2.3x the 5-day average, indicating strong participation.
Source: daily_prices:fmp_change_percent
Changes History →Coinbase is scheduled to report earnings on 2026-10-29 (consensus EPS estimate: −$0.14).
What changed: Nucor Corporation (NUE) moved -7.24% from $268.15 to $248.74 on 2026-08-19 after newly disclosed 13F regulatory filings revealed that Berkshire Hathaway reduced its Nucor stake by 52% during the second quarter under new CEO Greg Abel. Volume surged to 4.1x the 5-day average, reflecting elevated institutional trading.
Source: daily_prices:fmp_change_percent
Changes History →Nucor is scheduled to report earnings on 2026-10-26 with a consensus EPS estimate of $5.72.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.

Dell (DELL) Stock Falls More Than 6%: The AI-Server Boom Meets a Memory-Cost Squeeze
Dell fell about 6–7% to roughly $440 on August 19 — not on any demand warning (analysts actually raised targets that day), but as AI-hardware names lagged a firm market and investors refocused on a known worry: rising DRAM/NAND memory and HDD storage costs squeezing the already-thin margins on its booming AI servers, ahead of the September 1 earnings. It is the uncomfortable other side of the storage/memory super-cycle: soaring prices lift the makers (Micron and SanDisk in memory, Western Digital in hard drives) but raise input costs for system assemblers like Dell. After a ~218% one-year run and a re-rating to ~24× forward earnings on a ~19%-gross-margin business, the September print — where the AI-server margin line will show whether the squeeze is temporary or structural — is the key test. Analyst targets run from $360 to $700.

Merck (MRK) Stock Jumps to a 52-Week High: The Moderna Cancer-Vaccine Phase 3 Win and the Keytruda Cliff
Merck jumped more than 9% (about 11% intraday) to a 52-week high on August 19 after it and partner Moderna said their personalized mRNA cancer vaccine (intismeran/V940) plus Keytruda succeeded in a pivotal Phase 3 melanoma trial, meeting both recurrence-free and distant-metastasis-free survival goals. It matters because Keytruda — ~49% of Merck's revenue — faces a U.S. patent cliff in December 2028 (plus IRA pricing pressure), and this is the first Phase 3 win for a potential post-Keytruda growth platform. Moderna, for which the program is far more material, more than doubled. But after the pop to a 52-week high, Merck trades above the average analyst target (~$137) on a forward P/E near 16×, and the vaccine's revenue is still years — and a regulatory path — away.

Bloom Energy (BE) Stock Falls More Than 10%: The AI-Power Selloff, a $61B Valuation, and a Short-Seller Overhang
Bloom Energy fell more than 10% on August 18 (to around $207 by early afternoon) — not on any new company disclosure, but in a broad, rates- and macro-driven selloff of AI-infrastructure stocks (Vertiv −6.9%, GE Vernova −6.3% the same day) as long-dated Treasury yields hit multi-year highs. Bloom fell hardest, consistent with being an unusually high-beta name in the group (β 3.83), up ~360% in a year on data-center fuel-cell demand, trading near 60× forward earnings, with an unresolved short-seller allegation about its scandium supply chain hanging over it. The bull case is real — a first $1B quarter (+166% YoY), a master agreement to supply up to 2.8 GW to Oracle, and a $25B Brookfield financing partnership — but analyst targets from $97 to $390 capture just how contested the valuation is.

Intel (INTC) Stock Falls: A ~$23 Billion Raise, a SoftBank Headline, and the Turnaround Bet
Intel fell about 6% to roughly $97 on August 18, mostly in a broad chip-sector pullback (Micron −5.3%, Applied Materials −5.2%), with two Intel-specific overhangs: dilution from a ~$23 billion stock offering (242.1M shares at $95, the original $20B deal ~5× oversubscribed) and a viral 'SoftBank put 67% of its portfolio in Intel' statistic that really reflects price appreciation, not new buying. The bigger picture: a stock up ~296% in a year on a foundry-turnaround thesis. Intel is operating-profitable (Q2 operating income +$1.8B; Products +$4.8B, Foundry −$2.1B) even though its ~$11B GAAP net loss looks alarming — that loss is dominated by a $12.5B non-cash charge on shares owed to the U.S. government, now its largest shareholder at ~8.4%. Analyst targets from $75 to $200 capture a high-uncertainty bet.

Coherent (COHR) Stock Surge: A Record AI-Optical Quarter and the China-Transceiver Ban
Coherent jumped about 10% on August 17 to roughly $359, extending a surge built on three engines: a record fiscal Q4 (revenue $2.05 billion, +34%, with Datacenter & Communications now ~79% of sales) that triggered a wave of analyst target hikes to a $500 Street-high; a proposed U.S. FCC restriction on Chinese optical transceivers; and the broader AI-optical demand cycle. But the record quarter didn't jump the stock — it had already more than quadrupled and drifted after the print before rebounding. With the old merger leverage down to ~1.3x net debt/EBITDA, the debate is now valuation (~39x forward after the run, near the average target) and whether the contested China-transceiver policy actually lands.

Micron (MU) Stock Jumps on China-Memory Policy and a Bet That the Cycle Has Changed
Micron jumped about 5% on August 17 to roughly $1,023, joining a memory-and-storage rally after Commerce Secretary Lutnick said the U.S. 'does not approve' of Apple buying Chinese memory — a policy signal supportive for non-Chinese suppliers like Micron — building on New Street's Friday upgrade to Buy ($1,250) on a thesis that HBM has structurally shallowed memory's boom-and-bust cycle. Yet the stock trades at just ~7x forward earnings versus ~23x trailing: a durability discount, not a forecast of falling profits (consensus EPS actually rises from ~$73 to ~$155). With analyst targets spanning $361 to $2,200, the whole debate is whether today's elevated earnings prove durable through the cycle.











